Use of botulinum toxin type A in rheumatic diseases

The article presents an analysis of modern data on the antinociceptive effectiveness of botulinum toxin type A (BTA) in rheumatic diseases (RD). The prospects for the use of BTA in the treatment of pain in different RDs are discussed. We searched for publications in the Medline, Pubmed, Cochrane Lib...

Full description

Saved in:
Bibliographic Details
Main Authors: O. N. Egorova, B. S. Belov, E. G. Sazhina
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-10-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1208
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The article presents an analysis of modern data on the antinociceptive effectiveness of botulinum toxin type A (BTA) in rheumatic diseases (RD). The prospects for the use of BTA in the treatment of pain in different RDs are discussed. We searched for publications in the Medline, Pubmed, Cochrane Library databases. Analysis of literature data has shown that BTA can become an additional method of pain management in many RDs.
ISSN:1996-7012
2310-158X